![]() Idorsia Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. | ||
Founding Date | Founding Date 2003 | Founding Date 2017 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Allschwil, CH HQ Shanghai, CN Lörrach, DE Chiyoda City, JP | |
Employees | Employees 3,4721% increase | Employees 8007% increase |
Financial | ||
Revenue (est.) | Revenue (est.) Kč2.3b (FY, 2021) | Revenue (est.) CHF220.6m (FY, 2025) |
Cost of goods | Cost of goods Kč807.2m (FY, 2021) | Cost of goods CHF20.9m (FY, 2025) |
Gross profit | Gross profit Kč1.5b (FY, 2021) | Gross profit CHF214.3m (FY, 2025) |
Net income | Net income (Kč831.2m) (FY, 2021) | Net income (CHF111.7m) (FY, 2025) |

Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
View company